Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04767919 · ClinicalTrials.gov registry record · NA

MIP Versus PCNL for Kidney Stone Disease

A NA study of Kidney Stone, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
75
Enrollment target
6
Study locations

NCT04767919 is a NA study of Kidney Stone that has completed, run by University of California, San Diego. The registered enrollment target is 75 participants, below the 190-participant average among 28 other Kidney Stone trials with a reported enrollment target (61% lower). The trial reports 6 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04767919, a NA study of Kidney Stone, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target
6
Study locations

Study Summary

The decision to use standard percutaneous nephrolithotomy (PCNL) versus mini-percutaneous nephrolithotomy (MIP) has been a subject of much debate in the urological community. The investigators propose a randomized controlled trial to compare the operative outcomes and complications of mini-percutaneous nephrolithotomy (mini-PCNL) versus standard PCNL for renal stones. The results of this study will help guide the decision making regarding these two procedures in the US population and provide further insight into the utility and safety of these procedures. A cost analysis will be performed, and it is hypothesized that the reusable components of the Storz MIP set will result in lower costs of the mini-PCNL procedure compared to standard PCNL.

Conditions Studied

Kidney Stone

Interventions

  • PROCEDURE Standard Percutaneous Nephrolithotomy (sPCNL)
  • PROCEDURE Minimally Invasive Percutaneous Nephrolithotomy (MIP)

Study Locations (6)

Ohio

  • Cleveland Clinic - Cleveland
  • Ohio State Unversity - Columbus

Arizona

  • Mayo Clinic - Phoenix

California

  • University of California, San Diego, Medical Center - San Diego

Tennessee

  • Vanderbilt University Medical Center - Nashville

British Columbia

  • University Of British Columbia - Vancouver

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2021-01-01
Est. Completion 2024-06-07
Phase NA

Sponsor

University of California, San Diego

775 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04767919

The ClinicalTrials.gov registry entry for NCT04767919 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 190-participant average among 28 other Kidney Stone trials with a reported enrollment target (61% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Kidney Stone appearing as the primary indexed condition, and to 2 interventions - of which Standard Percutaneous Nephrolithotomy (sPCNL) is the first listed.

NCT04767919 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Ohio, Arizona, California.

Frequently Asked Questions

What is clinical trial NCT04767919 about?

NCT04767919 is a clinical study titled "MIP Versus PCNL for Kidney Stone Disease". The decision to use standard percutaneous nephrolithotomy (PCNL) versus mini-percutaneous nephrolithotomy (MIP) has been a subject of much debate in the urological community. The investigators propose a randomized controlled trial to compare the operative outcomes and complications of mini-percutane...

What is the current status of trial NCT04767919?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2021-01-01. Estimated completion is 2024-06-07.

What conditions does trial NCT04767919 study?

This clinical trial studies the following conditions: Kidney Stone.

What interventions are being tested in trial NCT04767919?

The interventions under investigation include: Standard Percutaneous Nephrolithotomy (sPCNL) (PROCEDURE), Minimally Invasive Percutaneous Nephrolithotomy (MIP) (PROCEDURE).

Who is sponsoring clinical trial NCT04767919?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04767919 being conducted?

This trial has 6 study locations across Arizona, California, Ohio, Tennessee, British Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Kidney Stone

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Kidney Stone

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.